Synthesis of 6-dimethyl amino-9- [3'- (O-methyl)S) -[UL-14C] -tyrosinylamino) -3'-deoxy-b-D -ribofuranosyl] Purine.

AP Mehotra, Martin Denis Ryan, D Gani

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

In order to investigate and further refine the mechanism of the unique cleavage activity of the 18 amino acid 2A region of the foot-and-mouth-disease virus (FMDV), the synthesis of C-14-labelled puromycin is required. Puromycin is an inhibitor of protein synthesis and is an analogue of the terminal aminoacyl-adenosine portion of aminoacyl-tRNA. A short and expedient four step synthesis of 6-dimethylamino-9-[3'-(O-methyl) (2S)-[UL-C-14]tyrosinylamino)-3'-deoxy-beta-D-ribofuranosyl] purine (C-14-labelled puromycin) starting from (2S)-[UL-C-14]-tyrosine is therefore described.

Original languageEnglish
Pages (from-to)623-634
Number of pages12
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume43
Publication statusPublished - May 2000

Keywords

  • puromycin
  • carbon-14
  • [UL-C-14]-tyrosine
  • FMDV 2A region
  • PUROMYCIN

Fingerprint

Dive into the research topics of 'Synthesis of 6-dimethyl amino-9- [3'- (O-methyl)S) -[UL-14C] -tyrosinylamino) -3'-deoxy-b-D -ribofuranosyl] Purine.'. Together they form a unique fingerprint.

Cite this